Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |